UK study: new drug shows promise against Toxoplasmosis

Findings from a new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry May 28 may lead to a new treatment against Toxoplasma gondii, the parasite that causes toxoplasmosis. The labs of Matthew Gentry, Ph.D., and Craig Vander Kooi, Ph.D., in the Department of Molecular and Cellular Biochemistry, Anthony Sinai, Ph.D., in the Department of Microbiology, Immunology and Molecular Genetics, and Zhong-Yin Zhang, Ph.D., at the Purdue Institute for Drug Discovery, collaborated to develop a drug that targets the cyst form of the parasite. Dr. Greg talks with Gentry about the breakthrough research.

Related Keywords

United Kingdom ,Vander Kooi ,Robert Murphy ,Craig Vander Kooi ,Jianping Lin ,Tiantian Chen ,Centers For Disease ,Department Of Microbiology ,Purdue Institute For Drug Discovery ,National Institute Of Allergy ,National Institutes Of Health ,Department Of Molecular ,National Institute Of Neurological Disorders ,From United Kingdom Now ,Disease Control ,Matthew Gentry ,Cellular Biochemistry ,Anthony Sinai ,Molecular Genetics ,Zhong Yin Zhang ,Purdue Institute ,Drug Discovery ,Provost Dipaola ,National Institute ,Neurological Disorders ,National Institutes ,Infectious Diseases ,National Cancer Institute ,